Latest News- Active Pharmaceutical Ingredient (API) Market in India: Captive APIs is expected to lead the Manufacturing Type segment during 2025-2029

The Active Pharmaceutical Ingredient (API) Market in India is being driven by Increasing number of type II drug master files (DMF)

The Active Pharmaceutical Ingredient (API) Market in India is expected to grow at a CAGR of 7.4% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 11184 million. In the Indian API market, there is a notable shift in manufacturing focus from generic drugs to complex and high-value APIs. This transition is driven by factors such as increasing global demand for specialty pharmaceuticals, the requirement for intricate APIs in novel therapeutics, and stringent regulatory requirements. Indian pharmaceutical companies are investing in advanced technologies and research capabilities to produce complex APIs, including those utilized in biologics and biosimilars. This emphasis on research and development fosters innovation in API synthesis techniques, process optimization, and green chemistry practices. 

Get more information on Active Pharmaceutical Ingredient (API) Market in India by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Manufacturing Type
  • Captive APIs
  • Contract APIs
• Type
  • Innovative APIs
  • Generic APIs
• Product Type
  • Prescription
  • Over-the-counter (OTC)
• Application
  • Cardiovascular diseases (CVDs)
  • Oncology
  • Infectious diseases
  • Diabetes
  • Others
• Geography
  • India

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing number of type II drug master files (DMF)
• Growing emphasis on biosimilars manufacturing
• Growing need to focus on core competencies

However, the market also witnesses some limitations, which are as follows:

• Stringent regulatory environment
• Shortage of API supply causing rise in prices in India
• Capacity utilization constraints

Benefits of Buying Global Active Pharmaceutical Ingredient (API) Market in India Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Active Pharmaceutical Ingredient (API) Market in India Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Active Pharmaceutical Ingredient (API) market in India is witnessing significant growth due to the increasing demand for APIs in the production of generic drugs for treating various health conditions. Key disease areas include infectious diseases, hospital-acquired infections, chronic diseases, and cardiovascular diseases. APIs can be derived from plant sources or synthetically, with the cardiology and oncology segments showing particular interest. Product development strategies focus on improving efficiency, reducing costs, and enhancing the quality of APIs.

Market Research Overview

The Active Pharmaceutical Ingredient (API) market in India is a significant segment of the global pharmaceuticals industry, encompassing companies involved in the research and development (R&D) or production of APIs for infectious diseases, hospital-acquired infections, chronic diseases, and cardiovascular diseases. According to Technavio, the global pharmaceuticals market is projected to grow due to several factors, including an aging population, with the proportion of individuals over 60 years old in the US and Europe predicted to increase significantly by 2050 and 2030, respectively. This demographic shift will drive demand for pharmaceutical solutions to address the health needs of an aging population. Additionally, advancements in technology and increasing healthcare expenditures will contribute to market growth. The global pharmaceuticals market size is calculated based on the combined revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/